Terms ending in 2035
Every in-force patent on Emory University's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,585,915 | Polypeptide Hydrogels and Uses Related Thereto In force · High confidence | Emory University | In force | High confidence | |
| US 9,840,693 | Polypeptide Hydrogels and Uses Related Thereto In force · High confidence | Emory University | In force | High confidence | |
| US 9,673,030 | Computer Readable Storage Mediums, Methods and Systems for Normalizing Chemical Profiles in Biological or Medical Samples Detected by Mass Spectrometry In force · High confidence | Emory University | In force | High confidence | |
| US 10,323,077 | Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer In force · High confidence | Emory University and Children's Healthcare of Atlanta, Inc. | In force | High confidence | |
| US 10,286,084 | Compositions for the Inactivation of Virus Replication and Methods of Making and Using the Same In force · High confidence | Emory University | In force | High confidence | |
| US 9,932,344 | Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use In force · High confidence | IP2IPO Innovations Limited | In force | High confidence | |
| US 10,414,772 | Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use In force · High confidence | IP2IPO Innovations Limited | In force | High confidence | |
| US 10,927,119 | Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use In force · High confidence | IP2IPO Innovations Limited | In force | High confidence | |
| US 11,566,029 | Pyrazolo[1,5-a]pyrimidine-5,7-diamine Compounds as CDK Inhibitors and Their Therapeutic Use In force · High confidence | IP2IPO Innovations Limited | In force | High confidence | |
| US 9,950,168 | Methods for Intracardiac Surgery and Intracardiac Delivery of Therapies and Devices In force · High confidence | Emory University | In force | High confidence | |
| 37 more term ends in 2035 · Pro | |||||
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
42 of these are in force and held by Emory University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.